PMID- 28393277
OWN - NLM
STAT- MEDLINE
DCOM- 20171227
LR  - 20181202
IS  - 1432-5233 (Electronic)
IS  - 0940-5429 (Linking)
VI  - 54
IP  - 7
DP  - 2017 Jul
TI  - Early screening for type 2 diabetes following gestational diabetes mellitus in 
      France: hardly any impact of the 2010 guidelines.
PG  - 645-651
LID - 10.1007/s00592-017-0986-x [doi]
AB  - AIMS: Women who had gestational diabetes mellitus (GDM) have a high risk of type 
      2 diabetes mellitus (T2DM) in the years following pregnancy. Most follow-up 
      screening studies have been conducted in limited geographical areas leading to 
      large variability in the results. The aim of our investigation was to measure how 
      the publication of guidelines affected early screening for T2DM after a pregnancy 
      with GDM during the period 2007-2013, in France. METHODS: We conducted a 
      retrospective cohort study in a representative sample of 1/97th of the French 
      population using data from the "National Health Insurance Inter-Regime 
      Information System," which collects individual hospital and non-hospital data for 
      healthcare consumption. RESULTS: The sample included 49,080 women who gave birth 
      in 2007-2013. In the following 3 months, only 18.49% of women with GDM had an 
      oral glucose tolerance test or a blood glucose test in 2007. This rate had not 
      significantly increased in 2013 (p = 0.18). The proportion of women with GDM who 
      had the recommended glycemic follow-up at 3 months (20.30 vs. 21.58%, p = 0.19) 
      and 6 months (32.48 vs. 37.16%, p = 0.08) was not significantly different before 
      the guidelines (2008-2009) and after the guidelines (2012-2013). At 12 months, 
      the difference was significant (46.77 vs. 54.05%, p = 0.009). CONCLUSION: 
      Postpartum screening has improved only slightly since the guidelines and remains 
      largely insufficient, with less than 25% of women with GDM screened in the first 
      3 months. In the first year after delivery, less than 60% of women were screened 
      for T2DM.
FAU - Goueslard, K
AU  - Goueslard K
AD  - Service de Biostatistique et d'Informatique Medicale (DIM), CHRU Dijon, 21000, 
      Dijon, France.
AD  - Universite de Bourgogne, 21000, Dijon, France.
FAU - Cottenet, J
AU  - Cottenet J
AD  - Service de Biostatistique et d'Informatique Medicale (DIM), CHRU Dijon, 21000, 
      Dijon, France.
AD  - Universite de Bourgogne, 21000, Dijon, France.
FAU - Mariet, A-S
AU  - Mariet AS
AD  - Service de Biostatistique et d'Informatique Medicale (DIM), CHRU Dijon, 21000, 
      Dijon, France.
AD  - Universite de Bourgogne, 21000, Dijon, France.
FAU - Sagot, P
AU  - Sagot P
AD  - Service de Gynecologie-Obstetrique et Medecine de la Reproduction, CHRU de Dijon, 
      Dijon, France.
FAU - Petit, J-M
AU  - Petit JM
AD  - Centre de Recherche INSERM Unite 866, University of Bourgogne Franche-Comte, 
      21000, Dijon, France. jean-michel.petit@chu-dijon.fr.
AD  - Services de Diabetologie et Endocrinologie, CHRU Dijon, 21000, Dijon, France. 
      jean-michel.petit@chu-dijon.fr.
FAU - Quantin, C
AU  - Quantin C
AD  - Service de Biostatistique et d'Informatique Medicale (DIM), CHRU Dijon, 21000, 
      Dijon, France.
AD  - Universite de Bourgogne, 21000, Dijon, France.
AD  - INSERM, CIC 1432, Dijon University Hospital, Clinical Investigation Center, 
      Clinical Epidemiology/Clinical Trials Unit, 21000, Dijon, France.
AD  - Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases 
      (B2PHI), INSERM, UVSQ, Institut Pasteur, Universite Paris-Saclay, Paris, France.
LA  - eng
PT  - Journal Article
DEP - 20170409
PL  - Germany
TA  - Acta Diabetol
JT  - Acta diabetologica
JID - 9200299
SB  - IM
MH  - Adult
MH  - Diabetes Mellitus, Type 2/*diagnosis/epidemiology
MH  - Diabetes, Gestational/*epidemiology/pathology
MH  - Early Diagnosis
MH  - Female
MH  - Follow-Up Studies
MH  - France/epidemiology
MH  - Glucose Tolerance Test
MH  - Humans
MH  - Mass Screening/*methods/standards
MH  - Postpartum Period
MH  - Practice Guidelines as Topic
MH  - Pregnancy
MH  - Retrospective Studies
OTO - NOTNLM
OT  - Gestational diabetes mellitus
OT  - Glucose test
OT  - Guidelines
OT  - Screening
OT  - Type 2 diabetes mellitus
EDAT- 2017/04/11 06:00
MHDA- 2017/12/28 06:00
CRDT- 2017/04/11 06:00
PHST- 2017/01/27 00:00 [received]
PHST- 2017/03/22 00:00 [accepted]
PHST- 2017/04/11 06:00 [pubmed]
PHST- 2017/12/28 06:00 [medline]
PHST- 2017/04/11 06:00 [entrez]
AID - 10.1007/s00592-017-0986-x [pii]
AID - 10.1007/s00592-017-0986-x [doi]
PST - ppublish
SO  - Acta Diabetol. 2017 Jul;54(7):645-651. doi: 10.1007/s00592-017-0986-x. Epub 2017 
      Apr 9.